share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K:諾和諾德-股票回購計劃
美股SEC公告 ·  09/16 13:32

Moomoo AI 已提取核心訊息

Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on August 7, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As of September 13, 2024, Novo Nordisk has repurchased 12,235,249 B shares at an average price of DKK 881.30 per share, totaling DKK 10,782,912,990. The transactions made under this program are detailed on the company's website. With the recent purchases, Novo Nordisk now holds 13,563,880 B shares as treasury shares, which is 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on August 7, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As of September 13, 2024, Novo Nordisk has repurchased 12,235,249 B shares at an average price of DKK 881.30 per share, totaling DKK 10,782,912,990. The transactions made under this program are detailed on the company's website. With the recent purchases, Novo Nordisk now holds 13,563,880 B shares as treasury shares, which is 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
諾和諾德公司是一家領先的全球醫療保健公司,一直在積極執行其股票回購計劃,該計劃於2024年8月7日宣佈。該計劃是一個更大計劃的一部分,將在從2024年2月6日開始的12個月期間回購價值高達200億丹麥克朗的股份。截至2024年9月13日,諾和諾德已經回購了122352490億股,平均每股價格爲881.30丹麥克朗,總額爲10782912990丹麥克朗。此計劃下的交易詳細記錄在公司網站上。通過最近的購買,諾和諾德現在持有135638800億股作爲庫藏股,這佔到了股本的0.3%。公司的總股數,包括庫藏股,在4465000000。諾和諾德的股票在納斯達克哥本哈根交易,並在紐約證券交易所交易。
諾和諾德公司是一家領先的全球醫療保健公司,一直在積極執行其股票回購計劃,該計劃於2024年8月7日宣佈。該計劃是一個更大計劃的一部分,將在從2024年2月6日開始的12個月期間回購價值高達200億丹麥克朗的股份。截至2024年9月13日,諾和諾德已經回購了122352490億股,平均每股價格爲881.30丹麥克朗,總額爲10782912990丹麥克朗。此計劃下的交易詳細記錄在公司網站上。通過最近的購買,諾和諾德現在持有135638800億股作爲庫藏股,這佔到了股本的0.3%。公司的總股數,包括庫藏股,在4465000000。諾和諾德的股票在納斯達克哥本哈根交易,並在紐約證券交易所交易。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息